Pirmenol enantiomers in dog plasma were quantitied using a stcrcospccific high-perfornlance liquid chromatographic method with ,dtraviolet detection at 262 nm. Racemic pirmenol and internal standard, ( + )-propranolol, were isolated t tom dog plasma by a three-step cxtr:tction procedure using toluene, 0.1 M hydrochloric acid and hexane, lespcctivcly. A chiral analytical column (Chiralcel O J) was used with a mobile phase consisting ofhexant,-isopropanol-dietlwlamine (98.9: !.0:0. I ). Linear calibration curves were obtained in the concentration range 0.0200-5.00 l~g/ml for each enantiomer. Precision of the method, expressed as coefticient of variation for nine quality control samples, was 7. i % For ( + )-pirmenol and 6.4% for (-)-pirmenol. Bias was • 2.2~/o for (+)-pirmenol and 4-1.5% for (-)-pirmenol in quality control samples.
INTRODUCTION

Pirmenol, ( 4-)-cis-oc-[3-(2,6-dimethyl-l-piperidinyl)propyl]-7-phenyl-2-pyridinemethanol monohydrochloride monohydrate, is a chiral compound
being investigated as an antiarrhythmic agent. Pirmenol ;s administered as a racemic mixture and its pharmacokinetics have been studied in healthy subjects and patients with dysrhythmia [I-4]. Analytical methods used for these studies quantified pirmenol as a racemi,: mixture without distinguishing between enantiomers [5, 6] . Investigatior~ of possible stereoselective differences in pharmacokinetics, metabolism and pharmacodynamics of pirmenol requires a n':.ethod for quantitation of its enantiomers in biological samples.
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• HCI -HzO Since derivatization of pirmenol was not successful, several chiral columns were investigated for the separation of pirmenol enantiomers. A chiral HyproCu-Daltosil column (Serva, New York, NY, USA) was first tried since it was reported to separate pirmenol enantiomers in dog and human urine [7] . However, this column did not provide adequate separation at typical racemic pirmenol concentrations in plasma (< 1.0 Itg/ml) following therapeutic doses. An ~-acid glycoprotein column (LKB EnantioPac, Bromma, Sweden) also separated pirmenol enantiomers, but racemic concentrations less than 0.5 Itg/rnl could not be quantified accurately. For pharmacokinetic studies, a detection limit of at least 0.1 ltg/ml racemic pirmenol would be required.
The method described uses cellulose tris(4-methylbenzoate) adsorbed on siW.ica gel [8] as a chiral stationary phase (Chiralcel O J, Daicel, Tokyo, Japan) for separation of pit menol enantiomers. Linearity, precision and accuracy were evaluated following analysis of calibration standards and quality control samples prepared in dog plasma. Possible differences in the pharmacokinetics and pharmacodynamics of each enantiomer are currently being evaluated using this high-performance liquid chromatographic (HPLC) method for quantitation of (+)-pirmenol and (-)-pirmenol in plasma.
EXPERIMENTAL
Chemicals
Racemic pirrnenol hydrochloride and pirmenol free base were synthesized, and pirmenol enantiomers were separated at the Parke-Davis Pharmaceutical Research Division, Warner Lambert (Ann Arbor, MI, USA). Internal standard used for the assay was (+)-propranolol hydrochloride (Sigma, St. Louis, MO, USA). Mobile phase consisted of HPLC-grade hexane (EM Science, Gibbstown, N J, USA), HPLC-grade isopropanol (Baxter, Burdick and Jackson Division, Muskegon, MI, USA) and diethylamine (Sigma). Glassware was silanized using a i0% solution of dichlorodilnethy!silane (Sigma) in HPLC-grade toluene (Baxter, Burdick and Jackson Division). t-Iydrochloric acid and sodium hydroxide solutions were prepared, using standard volumetric solutions purchased from J. T. Baker (Phillipsburg, N J, USA) with HPLC-grade water (EM Science). Control beagle dog plasma was obtained at the Parke-Davis Pharmaceutical Research Division, Warner Lambert. Control human plasma was purchased from Interstate Blood Bank (Memphis, TN, USA).
Prep¢:,'ation o./" sohttions
A 250 l~g/ml stock solution of racemic pirmenol and a 100 ltg]ml stock solution of (+)-propranolol were prepared in 0.01 M hydrochloric acid using silanized volumetric flasks. A 25 tlg/ml racemic pirmenol stock solution was prepared by dilution (1:I0) of the 250 ttg/ml stock solution. Concentrations represent free base equivalents. Stock solutions were diluted with 0.01 M hydrochloric acid for preparation of calibration standards in silanized volumetric flasks. Concentrations of pirmenol enantiomers in calibration standard solutions ranged from 0.100 to 25.0 ttg/ml. Internal standar,~ solution (2.50 /lg/ml) was prepared by dilution (! :40) of internal standard stock solution with 0.01 M hydrochloric acid.
Quality control samples containing racemic pirmenoi were prepared at 0.0600, 0.300 and 1.50 l~g/ml of each enantiomer. Appropriate volumes of 25 or 250 lLg/ml stock solutions were added to silmz,zed 25-mi volumetric flasks and brought to volume with control beagle clog l~,asma. Aliquots of quality control samples were stored at -15"C in silanized glass tubes.
Extraction procedure
For calibration standards, 0.5 ml of control dog plasma and 0.1 ml of calibration standard solution containing racemic pirmenol were combined in a 100 mm x 16 mm disposable glass culture tube. A 0.5-ml aliquot of dog plasma and 0.1 ml of 0.01 M hydrochloric acid were used for quality controls and study samples. A 0.1-ml aliquot of 2.5/tg/ml internal standard solution and 0.2 mi of 1 M sodium hydroxide were added to each tube. The mixture was extracted with 5 ml of toluene by shaking for 10 rain, centrifuged at 750 g for 5 rain, and the aqueous layer was frozen in a dry ice-acetone bath. The remaining toluene was transferred to a 15-ml disposable glass centrifuge tube, back-extracted with 0.5 ml of 0. I M hydrochloric acid by shaking for 10 min and centrifuged at 420 g for 5 rain. Th. ~ aqueous layer was frozen in a dry ice-acetone bath and tcluene was discarded. After thawing, 0.2 ml of 1 M sodium hydroxide was added and the mixture was extracted with hexane by shaking for 10 rain followed by centrifugation at 420 g for 5 rain. The aqueous layer was frozen in a dry ice-acetone bath and hexane was transferred to a silanized 75 mm × 12 mm disposable glass culture tube. Hexane was evaporated under nitrogen gas and the residue was dissolved in 200 ~tl of mobile phase. A 175-ltl aliquot was injected into the HPLC system.
Chromatography
The HPLC system consisted of a Model 590 solvent delivery module, a Model 712 autosampler, Models CHM and TCM column temperature-controlling system (Waters, Milford, MA, USA), and a Model 8490 ultraviolet absorbance detector and Chromjet integrator (Spectra-Physics, San Jose, CA, USA).
Pirmenol enantiomers and internal standard were separated using a Chiralcel OJ column with 10 Ftm particle size and dimensions of 25 cm x 4.6 mni I.D. (J. T. Baker) and a mobile phase of hexane-isopropanol-diethylamine (98.9:I.0:0.1, v/v). Flow-rate was 1.0 ml]min, column temperature was maintained at 65"C, and absorbance was monitored at 262 nm.
Assay validation
Calibration standards and quality control samples were analyzed in triplicate on three separate days for a total of nine determinations at each concentration. Calibration standard concentrations ranged from 0.0200 to 5.00 ltg/ml for (+)-pirmenol and (--)-pirmenoI (0.0400-10.0 /Lg/ml racemic pirmenol). Pirmenol enantiomer concentrations in quality control samples of dog plasma were 0.0600, 0.300 and 1.50 /~g/ml (0.120, 0.600 and 3.00 /~g/ml racemic pirmenol). Leastsquares linear regression with a weighting factor of 1/concentration was used to construct calibration curves for peak-height ratio as a function of pirmenol enantiomer concentration. Regression parameters (slope; y-intercept) were used to calculate (+)-pirmenol and (-)-pirmenol concentrations in calibration standards, quality control samples and #7 vivo plasma samples.
Reco l,erv
Recovery of pirmenol enantiomers from dog plasma was determined at calibration standard concentrations of 0.0500, 0.250 and 2.50 ltg/ml (+)-pirmenol and ( -)-pirmenol (0. 100, 0.500 and 5.00 llg/ml racemic pirmenol). Nine determinations were performed at each concentration. Peak heights of (+)-pirmenol, (-)-pirmcnol and internal standard following extraction from dog plasma were compared with n-man peak heights from nine injections of reference (non-extracted) standards. For reference standards, stock solutions of racemic pirmenol free base in isopropanol and (+)-propranolol hydrochloride (internal standard) in methanol were prepared. Aliquots of these stock solutions were pipetted into silanized volurnetric flasks, solvents were evaporated under nitrogen, and residue was dissolved in hexane-isopropano!-diethylamine (99.1:0.8:0.1, v/v).
Dog pNsma samples
A single 5 mg/kg intravenous dose of racemic pirmenoI was administered to two male beagle dogs. The dose was prepared in 0.9% saline and given as a 5-min infusion. Serial blood samples were obtained for 8 h following the end of the infusion. After centrifugation, plasma was separated and stored frozen at -15°C until assayed. Pirmenol enantiomer concentrations in dog plasma were determined using the method described. Pharmacokinetic parameters were calculated using non-compartmental methods [9] .
RESULTS AND DiaL?USSION
Chroma t ograldO,
Representative chron-mtograms of pirmenol enantiomers in dog plasma are shown in Fig. 2 , where retention times of (+)-pirmenol, (-)-pirmenol and internal standard are 7.4, 9.2 and 20.9 min, respectively. No chromatographic peaks at retention times of pirmenol enantiomers or internal standard were observed in control dog plasma. In addition, control human plasma did not show any interfering peaks, sagg~sting that this method may also be applicable to human plasma samples. Elution order of enantiomers was identified by comparing retention times of (+)-pirmenol and (--)-pirmenol reference standards to retention from racemic pirmenol.
Calibration standards
Calibration curves were linear over the concentration range 0.0200-5.00 pg/ml for (+)-pirmenol and (-)-pirmenol in dog plasma. Regression parameters (slope; y-intercept; coefficient of determination, r 2) calculated following analysis of nine sets of calibration standards are shown in Table I . Variability of slope, as judged by coefficient of variation, was less than 3.0% for both enantiomers.
Mean calculated concentrations of calibration standards analyzed in triplicate on three separate days are shown in Table II . The coefficient of variation (C.V.) for nine determinations was 5.9% or less for (+)-pirmenol and 7.9% or less for (-)-pirmenol. The bias, calculated as the percentage difference from theoretical concentration, was ±3.5% for (+)-pirmenol and ±5.5% for (-)-pirmenol. Table III contains mean calculated concentrations for quality control samples containing racemic pirmenol in dog plasma. Precision was at least 7.1% for each enantiomer in quality control samples, based on C.V. values for (+)-pirmenol and (-)-pirmenol. Calculated concentrations were within 2.2% of actual concentrations for both pirmenol enantiomers. Precision and accuracy were also evaluated for the three determinations performed on each day (intra-day) and for " Calibration standard concentrations ranged from 0.0250 to 5.00 Itg/ml pirmenol enantiomers. calibration standards analyzed on each of three days (inter-day). Intra-day assay precision (C.V.) ranged from 1.0 to 8.5% for (+)-pirmenol and fi'om 0.7 to 8.9% for (-)-pirmenol. Intra-day assay accuracy (bias) was 4-9.3% for (+)-pirmenol and -4-4.7% for (--)-pirmenol. Inter-day assay precision (C.V.) ranged from 2.5 to I0.5% and inter-day assay accuracy (bias) was within 4.2% for (+)-pirmenol. Inter-day precision (C.V.) ranged from !.5 to 9.5% and inter-day accuracy (bias) was within 4.7% for (-)-pirmenol.
Quality conlrols
TABLE II MEAN (n = 9) CALCULATED CONCENTRATIONS OF (+)-PIRMENOL AND ( -)-PIRMENOL IN CALIBRATION STANDARDS ANALYZED !N TRIPLICATE ON THREE SEPARATE DAYS
Conccn- (+)-Pirmenol (-)-Pirmenol tration added Mean concentration C.V. Bias Mean concen~.ration C.V. Bias (/tg/ml) found (ltglml) (%) (%) found (/tg/ml) (%) (%)
Reco very
Recovery of pirmenol enantiomers and internal standard from dog plasma is shown in TaL',e IV. Mean (n = 9) recovery was approximately 80% for both pirmenol enantiomers over the concentration range 0.0500-2.50/tg/ml, with C.V.
TABLE IV RECOVERY OF PIRMENOL ENANTIOMERS AND INTERNAL STANDARD FROM DOG PLASMA
Recovery is expressed as ratio of peak height for (+)-pirmenol, (-)-pirmenol or internal stand;lrd after extraction from dog plasma to mean peak height after nine injections of non-extracted standards. 
Stability
Stability data for pirmenol enantiomers in quality control samples are listed in Table V . These values represent single determinations of pirmenol enantiomer concentrations in quality controls which were analyzed with study samples. Pirmenol enantiomers showed no degradation and are considered stable in dog plasma stored at -15°C for at least four months. 
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